e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Asthma and lung immunology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Stephanie Korn (Mainz, Germany), Johannes Holstege, Antje Jahn, Christian Schulz, Karl-Christian Bergmann, Andrea Koch, Rainer Ehmann, Eckard Hamelmann, Roland Buhl, Stephanie Korn
Source:
International Congress 2015 – Asthma and lung immunology
Session:
Asthma and lung immunology
Session type:
Thematic Poster Session
Number:
1096
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stephanie Korn (Mainz, Germany), Johannes Holstege, Antje Jahn, Christian Schulz, Karl-Christian Bergmann, Andrea Koch, Rainer Ehmann, Eckard Hamelmann, Roland Buhl, Stephanie Korn. Patients with allergic and eosinophilic asthma in the German severe asthma registry. Eur Respir J 2015; 46: Suppl. 59, 1096
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Prevalence of refractory asthma in population with severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Comparison of clinical features of severe persistent asthma and refractory asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis
Source: Annual Congress 2013 –Asthma
Year: 2013
Chronic rhinosinusitis with and without nasal polyps and rhinitis in adult asthma. Frequency distribution and relationship with asthma control and severity (the IRIS-ASMA study)
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
First clinical trial of a new IgE-adsorber in allergic asthma
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Characterisation of asthma patients with persistent airflow obstruction
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Allergic versus non allergic asthma: What makes the difference?
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Early- and late-onsets of severe asthma are associated with divergent phenotypes of the disease
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Nasal symptoms and doctor-diagnosed chronic lung diseases
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Allergic disorders in relation to asthma and spastic bronchitis in children
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept